MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3760/cma.j.cn121090-20231208-00298

Медицинская библиотека · Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2024

[Venetoclax combined with dose-reduced HAD as induction treatment for patients with de-novo acute myeloid leukemia].

Yan Z S, Li Y, Zhang B, He J S, Li J S, Wei S N, Wang Q, Li Q L, Liu K Q, Mi Y C

Аннотация на английскомСтатьяПеревод в очереди

Аннотация

The efficacy and safety of venetoclax combined with reduced dose HAD regimen in the treatment of newly diagnosed acute myeloid leukemia (AML) was investigated. From May 2022 to January 2023, a total of 25 patients with newly diagnosed AML were treated with venetoclax combined with reduced-dose HAD regimen as induction therapy. Accoding to the 2017 ELN recommendations, 13 (52.0%) in favoable, 3 (12.0%) in intemediate, and 9 (36.0%) in adverse. The ORR (CR rate+PR rate) was 88.0%, and the CR rate was 84.0%. By May 30, 2023, with a median follow-up of 9 months, 1 year overall survival, event-free survival, and relapse-free survival were 100%, 94.7%, and 94.7%, respectively. All patients received 1-5 cycles of consolidation therapy and two median cycles. Treatment with venetoclax and reduced dose of HAD regimen in the treatment of patients with newly diagnosed AML was high effective and safe.

Для цитирования: Yan Z S, Li Y, Zhang B, He J S, Li J S, Wei S N, Wang Q, Li Q L, Liu K Q, Mi Y C. [Venetoclax combined with dose-reduced HAD as induction treatment for patients with de-novo acute myeloid leukemia].. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. 2024. DOI: 10.3760/cma.j.cn121090-20231208-00298.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.